Vion Pharmaceuticals, Inc.

Home

	ABOUT VION		PRODUCTS & PIPELINE		CLINICAL TRIALS		INVESTOR RELATIONS

WHAT'S NEW

Vion Poster at ASCO® Annual Meeting

Vion to Present Data on Onrigin™ at the ASCO® Annual Meeting

Vion Reports 2009 First Quarter Results • Quarterly Conference Call

Vion Receives a Standard Review from the FDA for its New Drug Application for Onrigin™

Vion's New Drug Application for Onrigin™ Accepted for Review by the FDA

Vion Reports 2008 Full-Year and Fourth-Quarter Results

Vion Submits New Drug Application for Onrigin™

Vion Presents Additional Survival Data on Onrigin™ (Laromustine) Injection at ASH Annual Meeting

Vion Poster Slides - 50th Annual Meeting of the American Society of Hematology (ASH)